Bcl-2 family member Bcl-G is not a proapoptotic protein

Cell Death and Disease

Volumn 3, Issue 10, 2012, Pages

  Giam, M ^a,b   Okamoto, T ^a,b,c   Mintern, J D ^a,b   Strasser, A ^a,b   Bouillet, P ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bcl 2 family; Bcl G

Indexed keywords

BH3 PROTEIN; MONOCLONAL ANTIBODY; PROTEIN; PROTEIN BCL 2; PROTEIN BCL G; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; EPITHELIUM CELL; FEMALE; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INTERACTION;

ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-2; TWO-HYBRID SYSTEM TECHNIQUES; VESICULAR TRANSPORT PROTEINS;

MUS;

EID: 84870519016     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.130     Document Type: Article

References (29)

1. Giam M, Huang DC, Bouillet P. BH3-only proteins and their roles in programmed cell death. Oncogene 2008; 27: S128-S136.
2. Hinds MG, Day CL. Regulation of apoptosis: uncovering the binding determinants. Curr Opin Struct Biol 2005; 15: 690-699.
3. Lomonosova E, Chinnadurai G. BH3-only proteins in apoptosis and beyond: an overview. Oncogene 2008; 27: S2-S19.
4. Guo B, Godzik A, Reed JC. Bcl-G, a novel pro-apoptotic member of the Bcl-2 family. J Biol Chem 2001; 276: 2780-2785.
5. Nakamura M, Tanigawa Y. Characterization of ubiquitin-like polypeptide acceptor protein, a novel pro-apoptotic member of the Bcl2 family. Eur J Biochem 2003; 270: 4052-4058.
6. Heng TS, Painter MW. The Immunological Genome Project: networks of gene expression in immune cells. Nat Immunol 2008; 9: 1091-1094.
7. Chen M, Huang L, Wang J. Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity. Blood 2007; 109: 4360-4367.
8. Chen M, Huang L, Shabier Z, Wang J. Regulation of the lifespan in dendritic cell subsets. Mol Immunol 2007; 44: 2558-2565.
9. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47-59.
10. Strasser A, Cory S, Adams JM. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 2011; 30: 3667-3683.
11. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17: 393-403.
12. Liu X, Pan Z, Zhang L, Sun Q, Wan J, Tian C et al. JAB1 accelerates mitochondrial apoptosis by interaction with proapoptotic BclGs. Cell Signal 2008; 20: 230-240.
13. Coultas L, Pellegrini M, Visvader JE, Lindeman GJ, Chen L, Adams JM et al. Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region. Cell Death Differ 2003; 10: 185-192.
14. Giam M, Mintern JD, Rautureau GJP, Hinds MG, Strasser A, Bouillet P. Detection of Bcl-2 family member Bcl-G in mouse tissues using new monoclonal antibodies. Cell Death and Disease 2012; 3: e-pub ahead of print 23 August 2012; doi:10.1038/cddis.2012.117.
15. Sacher M, Kim YG, Lavie A, Oh BH, Segev N. The TRAPP complex: insights into its architecture and function. Traffic 2008; 9: 2032-2042.
16. Yu S, Satoh A, Pypaert M, Mullen K, Hay JC, Ferro-Novick S. mBet3p is required for homotypic COPII vesicle tethering in mammalian cells. J Cell Biol 2006; 174: 359-368.
17. Montpetit A, Larose J, Boily G, Langlois S, Trudel N, Sinnett D. Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia. Leukemia 2004; 18: 1499-1504.
18. Latil A, Bieche I, Chene L, Laurendeau I, Berthon P, Cussenot O et al. Gene expression profiling in clinically localized prostate cancer: a four-gene expression model predicts clinical behavior. Clin Cancer Res 2003; 9: 5477-5485.
19. Abdelhaleem M, Yi Q, Beimnet K, Hitzler J. A novel TEL-AML1 fusion transcript involving the pro-apoptotic gene BCL-G in pediatric precursor B acute lymphoblastic leukemia. Leukemia 2006; 20: 1294.
20. Lin ML, Park JH, Nishidate T, Nakamura Y, Katagiri T. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family. Breast Cancer Res 2007; 9: R17.
21. Kamath AT, Henri S, Battye F, Tough DF, Shortman K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002; 100: 1734-1741.
22. Nopora A, Brocker T. Bcl-2 controls dendritic cell longevity in vivo. J Immunol 2002; 169: 3006-3014.
23. Hon H, Rucker EB III, Hennighausen L, Jacob J. bcl-xL is critical for dendritic cell survival in vivo. J Immunol 2004; 173: 4425-4432.
24. Fuertes Marraco SA, Scott CL, Bouillet P, Ives A, Masina S, Vremec D et al. Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo. PLoS One 2011; 6: e20189.
25. Coultas L, Bouillet P, Loveland KL, Meachem S, Perlman H, Adams JM et al. Concomitant loss of proapoptotic BH3-only Bcl-2 antagonists Bik and Bim arrests spermatogenesis. Embo J 2005; 24: 3963-3973.
26. Lemckert FA, Sedgwick JD, Korner H. Gene targeting in C57BL/6 ES cells. Successful germ line transmission using recipient BALB/c blastocysts developmentally matured in vitro. Nucleic Acids Res 1997; 25: 917-918.
27. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994; 76: 17-27.
28. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 2000; 164: 2978-2986.
29. Wilson NS, Behrens GM, Lundie RJ, Smith CM, Waithman J, Young L et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs crosspresentation and antiviral immunity. Nat Immunol 2006; 7: 165-172.